Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -1.18% is 122% below its 5-year average of 5.47%, near the low end of its 5-year range (-1.18%–10.05%).
230.39% below its 12-month average of 0.91%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -0.86%.
RETURN ON ASSETS (ROA)
-1.18%
RETURN ON ASSETS (ROA) AVG TTM
0.91%
RETURN ON ASSETS (ROA) AVG 3Y
5.02%
RETURN ON ASSETS (ROA) AVG 5Y
5.47%
RETURN ON ASSETS (ROA) AVG 10Y
6.07%
RETURN ON ASSETS (ROA) AVG 15Y
5.60%
RETURN ON ASSETS (ROA) AVG 20Y
5.39%
CURRENT VS TTM AVG
-230.39%
CURRENT VS 3Y AVG
-123.52%
CURRENT VS 5Y AVG
-121.56%
CURRENT VS 10Y AVG
-119.44%
CURRENT VS 15Y AVG
-121.08%
CURRENT VS 20Y AVG
-121.87%
SECTOR MEDIAN · HEALTHCARE
-25.17%
median of 451 covered companies
CURRENT VS SECTOR MEDIAN
+95.31%
vs the sector median at left
Bruker Corporation
Market Cap
$9.72B
Return on Assets (ROA)
-1.18%
TTM Avg
0.91%
3Y Avg
5.02%
5Y Avg
5.47%
Market Cap
$9.60B
Return on Assets (ROA)
3.54%
TTM Avg
3.68%
3Y Avg
4.39%
5Y Avg
5.01%
Market Cap
$9.39B
Return on Assets (ROA)
11.86%
TTM Avg
10.65%
3Y Avg
7.37%
5Y Avg
5.11%
Market Cap
$10.07B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$10.08B
Return on Assets (ROA)
6.59%
TTM Avg
6.34%
3Y Avg
6.05%
5Y Avg
6.29%
Market Cap
$9.35B
Return on Assets (ROA)
-1.18%
TTM Avg
0.91%
3Y Avg
5.02%
5Y Avg
5.47%
Market Cap
$10.13B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
Market Cap
$10.22B
Return on Assets (ROA)
2.17%
TTM Avg
-6.26%
3Y Avg
-11.14%
5Y Avg
1.46%
Market Cap
$10.33B
Return on Assets (ROA)
9.76%
TTM Avg
6.05%
3Y Avg
5.92%
5Y Avg
6.23%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bruker Corporation (BRKR) | $9.72B | -1.18% | 0.91% | 5.02% | 5.47% |
| Henry Schein, Inc. (HSIC)vs › | $9.60B | 3.54% | 3.68% | 4.39% | 5.01% |
| Insulet Corp. (PODD)vs › | $9.39B | 11.86% | 10.65% | 7.37% | 5.11% |
| Align Technology, Inc. (ALGN)vs › | $10.07B | 6.44% | 6.68% | 6.69% | 12.75% |
| The Ensign Group, Inc. (ENSG)vs › | $10.08B | 6.59% | 6.34% | 6.05% | 6.29% |
| Bruker Corporation (BRKRP)vs › | $9.35B | -1.18% | 0.91% | 5.02% | 5.47% |
| Molina Healthcare, Inc. (MOH)vs › | $10.13B | -0.04% | 5.29% | 6.08% | 6.13% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.22B | 2.17% | -6.26% | -11.14% | 1.46% |
| Globus Medical, Inc. (GMED)vs › | $10.33B | 9.76% | 6.05% | 5.92% | 6.23% |
| Axsome Therapeutics, Inc. (AXSM)vs › | $9.11B | -25.17% | -38.54% | -43.55% | -63.00% |
ROA
-1.2%
ROE
-3.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -0.14% |
| 2024-12-31 | 1.95% |
| 2023-12-31 | 10.05% |
| 2022-12-31 | 8.21% |
| 2021-12-31 | 7.59% |
| 2020-12-31 | 5.18% |
| 2019-12-31 | 7.12% |
| 2018-12-31 | 8.44% |
| 2017-12-31 | 4.03% |
| 2016-12-31 | 8.47% |
| 2015-12-31 | 5.87% |
| 2014-12-31 | 3.04% |
| 2013-12-31 | 4.03% |
| 2012-12-31 | 4.17% |
| 2011-12-31 | 5.40% |
| 2010-12-31 | 6.16% |
| 2009-12-31 | 6.93% |
| 2008-12-31 | 5.81% |
| 2007-12-31 | 5.70% |
| 2006-12-31 | 4.27% |
| 2005-12-31 | 1.01% |
| 2004-12-31 | -2.11% |
| 2003-12-31 | -5.00% |
| 2002-12-31 | -3.05% |
| 2001-12-31 | 1.92% |
| 2000-12-31 | 1.22% |
| 1999-12-31 | 1.86% |
| 1998-12-31 | -1.39% |
